Profile data is unavailable for this security.
About the company
Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
- Revenue in USD (TTM)880.32m
- Net income in USD-602.74m
- Incorporated1981
- Employees2.97k
- LocationNeogen Corp620 Lesher PlLANSING 48912-1509United StatesUSA
- Phone+1 (517) 372-9200
- Fax+1 (517) 372-2006
- Websitehttps://www.neogen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novocure Ltd | 655.35m | -136.23m | 1.53bn | 1.61k | -- | 4.43 | -- | 2.33 | -1.22 | -1.22 | 5.88 | 3.03 | 0.6409 | 4.35 | 8.01 | 408,319.60 | -13.32 | -11.74 | -25.57 | -15.63 | 74.73 | 76.71 | -20.79 | -23.31 | 2.71 | -- | 0.3642 | -- | 8.28 | 5.80 | 19.21 | -- | 12.23 | -- |
| AtriCure Inc | 534.53m | -11.45m | 1.54bn | 1.35k | -- | 3.14 | 169.94 | 2.89 | -0.241 | -0.241 | 11.19 | 9.88 | 0.8461 | 1.74 | 8.42 | 395,946.70 | -1.81 | -2.67 | -2.07 | -2.98 | 74.98 | 74.88 | -2.14 | -4.13 | 2.99 | -6.75 | 0.1232 | -- | 14.88 | 20.95 | 74.39 | -- | 23.40 | -- |
| UFP Technologies Inc | 602.80m | 68.31m | 1.57bn | 4.85k | 23.29 | 3.71 | 17.98 | 2.61 | 8.76 | 8.76 | 77.29 | 54.95 | 0.9389 | 4.96 | 7.19 | 124,390.60 | 10.64 | 10.57 | 12.06 | 12.07 | 28.27 | 27.60 | 11.33 | 11.12 | 1.52 | 9.46 | 0.2422 | 0.00 | 19.50 | 27.43 | 15.82 | 38.57 | 24.23 | -- |
| Tandem Diabetes Care Inc | 1.01bn | -204.71m | 1.60bn | 2.50k | -- | 10.30 | -- | 1.58 | -3.07 | -3.07 | 15.08 | 2.27 | 1.10 | 3.37 | 7.25 | 405,894.40 | -22.15 | -12.88 | -30.13 | -16.00 | 53.81 | 52.12 | -20.17 | -14.32 | 2.02 | -6.00 | 0.6699 | -- | 7.93 | 15.26 | -113.18 | -- | -9.19 | -- |
| Inspire Medical Systems Inc | 911.98m | 145.42m | 1.84bn | 1.33k | 12.94 | 2.35 | 11.53 | 2.02 | 4.97 | 4.97 | 30.75 | 27.33 | 1.06 | 1.18 | 8.57 | 684,156.80 | 16.95 | 3.09 | 19.00 | 3.48 | 85.39 | 84.83 | 15.95 | 3.05 | 4.56 | -- | 0.00 | 0.00 | 13.60 | 51.21 | 171.77 | -- | 73.41 | -- |
| Artivion Inc | 441.33m | 9.76m | 1.84bn | 1.80k | 193.79 | 4.11 | 57.21 | 4.18 | 0.1987 | 0.1987 | 9.44 | 9.37 | 0.5273 | 1.82 | 5.22 | 245,183.30 | 1.17 | -1.72 | 1.30 | -1.86 | 64.40 | 64.69 | 2.21 | -3.80 | 2.62 | 1.44 | 0.3278 | -- | 13.59 | 11.75 | 173.17 | -- | 39.74 | -- |
| Omnicell Inc | 1.18bn | 2.05m | 1.89bn | 3.58k | 960.90 | 1.52 | 23.05 | 1.59 | 0.0432 | 0.0432 | 25.70 | 27.36 | 0.5786 | 7.19 | 5.01 | 330,962.30 | 0.1002 | 0.7331 | 0.1357 | 0.9767 | 42.49 | 44.88 | 0.1732 | 1.32 | 1.22 | -- | 0.1198 | 0.00 | 6.53 | 5.84 | -83.62 | -42.34 | 1.93 | -- |
| Alphatec Holdings Inc | 764.16m | -143.36m | 1.97bn | 913.00 | -- | 157.20 | -- | 2.57 | -0.9598 | -0.9598 | 5.09 | 0.2398 | 0.9754 | 1.35 | 7.86 | 836,971.50 | -18.30 | -24.58 | -24.00 | -31.32 | 69.60 | 67.58 | -18.76 | -32.07 | 1.28 | -1.28 | 0.9402 | -- | 24.95 | 39.46 | 11.57 | -- | 16.50 | -- |
| Heartflow Inc | -100.00bn | -100.00bn | 2.04bn | 699.00 | -- | 7.85 | -- | -- | -- | -- | -- | 3.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 44.32 | -- | 22.04 | -- | -- | -- |
| Establishment Labs Holdings Inc | 211.08m | -51.06m | 2.09bn | 1.00k | -- | 88.54 | -- | 9.88 | -1.74 | -1.74 | 7.17 | 0.8035 | 0.5997 | 0.788 | 2.96 | 210,235.10 | -14.51 | -27.03 | -18.45 | -33.98 | 69.32 | 66.79 | -24.19 | -39.79 | 2.00 | -2.12 | 0.9131 | -- | 27.14 | 20.04 | 39.64 | -- | 11.46 | -- |
| Neogen Corp | 880.32m | -602.74m | 2.35bn | 2.97k | -- | 1.12 | -- | 2.67 | -2.78 | -2.78 | 4.05 | 9.67 | 0.2375 | 2.63 | 5.95 | 296,005.00 | -16.26 | -7.73 | -16.94 | -8.06 | 45.98 | 48.10 | -68.47 | -27.91 | 2.80 | -0.2109 | 0.2737 | -- | -3.20 | 16.43 | -11,491.59 | -- | 34.18 | -- |
| LeMaitre Vascular Inc | 249.60m | 57.73m | 2.42bn | 646.00 | 43.03 | 6.16 | 35.57 | 9.71 | 2.47 | 2.47 | 10.72 | 17.28 | 0.4276 | 1.05 | 7.84 | 386,380.80 | 9.89 | 9.27 | 10.49 | 9.98 | 71.53 | 67.70 | 23.13 | 18.33 | 10.95 | -- | 0.300 | 36.37 | 13.53 | 14.05 | 31.10 | 22.16 | 17.86 | 18.10 |
| DENTSPLY SIRONA Inc | 3.68bn | -598.00m | 2.68bn | 14.00k | -- | 2.00 | -- | 0.7295 | -3.00 | -3.00 | 18.44 | 6.71 | 0.6582 | 3.05 | 5.92 | 262,857.20 | -10.70 | -5.83 | -14.50 | -7.12 | 50.00 | 52.93 | -16.25 | -11.12 | 1.03 | 4.77 | 0.6347 | -- | -2.98 | 1.96 | 34.29 | -- | 8.53 | 9.86 |
| 10X Genomics Inc | 642.82m | -43.54m | 2.86bn | 1.18k | -- | 3.59 | -- | 4.45 | -0.3496 | -0.3496 | 5.15 | 6.24 | 0.6559 | 2.85 | 9.53 | 545,690.10 | -4.44 | -14.35 | -5.16 | -16.43 | 69.13 | 72.27 | -6.77 | -24.50 | 4.09 | -- | 0.00 | -- | 5.25 | 16.55 | 76.16 | -- | -31.16 | -- |
| Integer Holdings Corp | 1.85bn | 102.83m | 2.96bn | 11.00k | 29.95 | 1.69 | 12.68 | 1.60 | 2.87 | 2.87 | 52.83 | 50.85 | 0.5714 | 5.37 | 4.59 | -- | 3.17 | 3.26 | 3.41 | 3.51 | 27.39 | 26.88 | 5.55 | 6.07 | 2.23 | 6.04 | 0.41 | -- | 7.98 | 11.54 | -15.05 | 5.89 | 12.09 | -- |
| Haemonetics Corp | 1.32bn | 175.44m | 3.01bn | 3.02k | 17.77 | 3.32 | 10.43 | 2.28 | 3.64 | 3.64 | 27.40 | 19.46 | 0.525 | 1.58 | 6.47 | 436,081.70 | 6.99 | 5.41 | 8.30 | 6.55 | 59.32 | 53.20 | 13.31 | 9.18 | 1.15 | 12.69 | 0.5733 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
Data as of Mar 05 2026. Currency figures normalised to Neogen Corp's reporting currency: US Dollar USD
54.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 29.72m | 13.66% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 22.11m | 10.17% |
| Clarkston Capital Partners LLCas of 31 Dec 2025 | 11.33m | 5.21% |
| ING Bank NV (Investment Management)as of 31 Dec 2025 | 8.78m | 4.04% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 8.72m | 4.01% |
| Gates Capital Management, Inc.as of 31 Dec 2025 | 8.39m | 3.86% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2025 | 8.18m | 3.76% |
| Mackenzie Financial Corp.as of 31 Dec 2025 | 7.90m | 3.63% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 7.30m | 3.36% |
| CIBC World Markets Corp.as of 31 Dec 2025 | 6.86m | 3.16% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
